WST Stock Price Today (November 2026) — West Pharmaceutical Services, Inc. Analysis & Key Metrics 2026-11-19
West Pharmaceutical Services, Inc. (WST) is trading at $396.69, down 1.81% today (as of November 2026).The stock is trading above its 50-day and 200-day moving averages.
- According to consensus analyst estimates, the 1-year price target is $471.00 (18.7% upside).
- Volatility is moderate (27.83% annualized), between 25% and 40%.
- From the latest financial filings: Revenue grew 8.70% in the latest quarter compared with the same quarter a year earlier. Debt is 0.11 times shareholders' equity.
WST Stock Analysis: Key Metrics & Valuation (November 2026)
Key figures from the latest data
West Pharmaceutical Services, Inc. - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $27.48B
P/E Ratio
Forward P/E: 38.17
Revenue Growth
Latest quarter vs year ago
Analyst Target
+18.7% upside potential
Key Investor Questions About WST
What the latest data shows
WST is trading above its 50-day and 200-day moving averages, and its RSI of 47.6 is in the neutral zone (between 30 and 70).
- Technicals: Neutral (RSI 47.63) (Uptrend: above 50- and 200-day averages)
- Fundamentals: Revenue +8.7%, debt/equity 0.11x
Revenue grew 8.70% in the latest quarter compared with the same quarter a year earlier.
- Total debt is $313.90M (0.11 times equity).
- 30-day volatility is 27.83% annualized, which counts as moderate (between 25% and 40%).
52-Week Trading Range
Over the past year, WST stock traded between $223.37 and $437.99 and currently trades near the high end of that range.
Volatility & Risk Profile
30-day volatility is 27.83% annualized, which counts as moderate (between 25% and 40%). Beta 0.66: the stock has moved much less than the market.
Institutional & Insider Ownership
Short interest is 3.04% of the float.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines, coverage and TickZen analysis
Market news
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
Al Gore's Top Q3 2026 Move: West Pharmaceutical Services Inc at a -4.16% Portfolio Impact
West Pharmaceutical Services (WST) Stock May Be 29% Overvalued On Cash Flow Views
How Investors Are Reacting To West (WST) Earnings Beat
West Pharmaceutical Services (WST) Lifted Its Outlook, Is The Stock Fully Priced?
Latest TickZen Insights
All insights →No TickZen article on WST yet. Our newest analysis:
Explore More Analysis for WST
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
No upcoming report date yet
Frequently Asked Questions
Common investor questions about West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) is currently trading at $396.69. The RSI (14-day) is 47.6, in the neutral zone (between 30 and 70). The mean analyst price target of $471.00 implies 18.7% upside from current levels. 30-day volatility is 27.83% annualized, which counts as moderate (between 25% and 40%).
Based on current valuation metrics for West Pharmaceutical Services, Inc. (WST): The trailing P/E ratio is 44.52. The forward P/E is 38.17, lower than the trailing P/E, suggesting analysts expect earnings improvement. Price-to-Book is 9.33. Price-to-Sales is 8.14. Different industries trade at different multiples, so these figures are most useful next to Medical Instruments & Supplies peers.
Based on 15 analysts covering WST, the consensus price target is $471.00. This represents a 18.7% upside from the current price of $396.69. The range spans from a low target of $340.00 to a high target of $500.00, reflecting varying levels of optimism among analysts. Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, West Pharmaceutical Services, Inc. (WST) pays a dividend with a current yield of approximately 0.26%. The annualized dividend rate is $0.88 per share. The payout ratio is 9.9%, which is conservative and suggests the dividend is well-covered by earnings with room for future increases. The most recent ex-dividend date was Nov 10, 2026.
Key risks for West Pharmaceutical Services, Inc. (WST) shown in the latest data: 1. Moderate volatility (27.8% annualized, between 25% and 40%). 2. Moves in the broader stock market (Beta 0.66: the stock has moved much less than the market).
Here is West Pharmaceutical Services, Inc.'s (WST) current debt and financial health profile: Total debt stands at $313.90M. The debt-to-equity ratio is 0.11x, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 2.82, indicating strong short-term liquidity. The quick ratio is 1.91. The company holds $464.10M in cash and equivalents. Free cash flow is positive at $453.40M, providing a cushion for debt servicing and shareholder returns.